Organisation paid for research Program year 2025 Source: CMS Open Payments

Private Practice Leadership LLC

Neither a doctor nor a teaching hospital

Research payments

$453,197

376 payments

Through program year 2025, Private Practice Leadership LLC is reported as receiving $453,197 in research payments, across 376 payments.

By program year

5 rows
Year Kind Amount Payments
2025 Research $88,702 80
2024 Research $34,684 3
2021 Research $37,954 48
2020 Research $62,151 94
2019 Research $229,705 151

Breakdown

Who paid Research payments · program years 2019–2025
  1. Boehringer Ingelheim International GmbH $227,095 330 payments
  2. Boehringer Ingelheim Pharma GmbH & Co.KG $226,101 46 payments
Studies the money was for Research payments · program years 2019–2025
  1. Empagliflozin and heart failure (HFpEF) $329,810 293 payments
  2. EASi-HF A Phase III double-blind, randomised, parallel-group superiority trial to evaluate efficacy and safety of the combined use of oral BI 690517 and empagliflozin compared with placebo and empagliflozin in participants with symptomatic heart failure (HF: NYHA II-IV) and left ventricular ejection fraction (LVEF) $88,702 80 payments
  3. BI 690517+Empa - Placebo+Empa in patients w. HF (LVEF) $34,684 3 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record